More than three dozen attorneys general are urging the FDA to take “decisive action” against counterfeit obesity drugs.
A telehealth company partnered with a pharmacy that lacked a required license, raising doubts about the safety and efficacy ...
Zealand’s CEO Adam Steensberg said that the company is “exactly where it wants to be” in terms of its partnering and ...
President Donald Trump and HHS Secretary Robert F. Kennedy Jr. said they will be studying the "threat" to children posed by ...
A small semaglutide trial suggests the medicine's suppression of appetite may extend to alcohol, but larger tests are needed ...
Dr. Robert Califf, the former chief of the Food and Drug Administration ... was struggling with obesity and Type 2 diabetes. Then he started taking Ozempic, the Novo Nordisk diabetes drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results